medigraphic.com
ISSN 1995-9427 (Print)

2021, Number 3

<< Back Next >>

Invest Medicoquir 2021; 13 (3)

Echocardiographic evaluation of septic cardiomyopathy. Importance of biomarkers

Pérez AG, Quevedo BY

Language: Spanish
References: 22
Page:
PDF size: 390.42 Kb.


ABSTRACT

Introduction. Sepsis-induced myocardial dysfunction (DMS) is one of the most clinically relevant manifestations in sepsis and one of the most early organic dysfunctions in septic shock. Echocardiography allows qualitative and quantitative evaluation of morphology and cardiac function, it is the first line of non-invasive technique for hemodynamic evaluation in septic patients with cardiovascular alterations. Troponin and ProBNP are indicators of severity of myocardial dysfunction. Methods. A descriptive, observational, cross-sectional study was conducted in patients diagnosed with sepsis and septic shock in the period from May 2018 - May 2019 at the Center for Surgical Medical Research, assessing ventricular function by echocardiography, measuring the values of ultrasensitive troponin I and ProBNP. Out of a total of 54 patients; 32 patients met the inclusion and exclusion criteria. Results. DMS was present in 14 patients (43.75%) of the sample studied, the average age of the samples was 67±16.5 years, 71.3% had some degree of systolic dysfunction and 100% had alterations in diastolic function of the VI, this group of patients was characterized by higher troponin I and ProBNP values and higher score on the Sequential Organ Failure Assessment (SOFA) scale. Mortality was 50% in these patients (p-0.04). Conclusion. DMS is common, is related to high biomarker values and high mortality in relation to patients who did not.


REFERENCES

  1. Quevedo Y, Pérez G, Anselmo A, et al. Evaluación de la función ventricular sistólica y diastólica por ecocardiografía en pacientes sépticos. Invest. Medicoquir 2020 (enero-abril); 12 (1) ISSN: 1995-9427, RNPS: 2162.

  2. Narváez I. et al. Incidence and evolution of sepsis-induced cardiomyopathy in a cohort of patients with sepsis and septic shock. Med Intensiva.2018;42(5):283-291.http://dx.doi.org/10.1016/j.medin.2017.08.008.

  3. Quevedo Y, Pérez G, Anselmo A, et al. El corazón en la sepsis Invest. Medicoquir 2020 (mayo-agosto); 12 (2) ISSN: 1995-9427, RNPS: 2162.

  4. Martin L, Derwall M, Al ZS, Zechendorf E, Reuter DA, Thiemermann C, et al. The septic heart: current understanding of molecular mechanisms and clinical implications. Chest 2019; 155:427–437. doi: 10.1016/j.chest.2018.08.1037. [PubMed] [Google Scholar]

  5. Boissier F, Razazi K, Seemann A, et al. Left ventricular systolic dysfunction during septic shock: The role of loading conditions. Intensive Care Med, 43 (2017), pp. 633-642 http://dx.doi.org/10.1007/s00134-017-4698-z | Medline

  6. Rolando G, Espinoza E.D, Avid E, et al. Prognostic value of ventricular diastolic dysfunction in patients with severe sepsis and septic shock.Rev Bras Ter Intensiva., 27 (2015), pp. 333-339 http://dx.doi.org/10.5935/0103-507X.20150057 | Medline

  7. Prabhu M.M, Yalakala S.K, Shetty R,etal. Prognosis of left ventricular systolic dysfunction in septic shock patients. J Clin Diagn Res., 9 (2015), pp. OC05-OC08 http://dx.doi.org/10.7860/JCDR/2015/10812.5640 | Medline

  8. Vallabhajosyula S, Sakhuja A, Geske JB, et al. Role of admission troponin-T and serial troponin-T testing in predicting outcomes in severe sepsis and septic shock. J Am Heart Assoc. 2017;6(9). pii: e005930. [ Links ]

  9. Pandompatam G, et al. The role of natriuretic peptides in the management, outcomes and prognosis of sepsis and septic shock, Rev. bras. ter. intensiva vol.31 no.3 São Paulo July/Sept. 2019 Epub Oct 14, 2019 https://doi.org/10.5935/0103-507x.20190060.

  10. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315: 801-10.

  11. Lang, R et al. Recomendaciones para la Cuantificación de las Cavidades Cardíacas por Ecocardiografía en Adultos: Actualización de la Sociedad Americana de Ecocardiografía y de la Asociación Europea de Imagen Cardiovascular. J Am Soc Echocardiogr 2015; 28:1-39.

  12. Nagueh S, et al. Recommendations for the evaluations of left ventricular diastolic function by echocardiography: An Update from the American Society of echocardiography and the European Association of cardiovascular imaging J Am Soc Echocardiogr 2016; 29:277-314.

  13. Pulido J.N , Afessa B,. Masaki M, et al.Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock.Mayo Clin Proc, 87 (2012), pp. 620-628 http://dx.doi.org/10.1016/j.mayocp.2012.01.018 | Medline

  14. Wang J, Wang XT, Liu DW, Zhang HM, Su LX. Induction and deduction in sepsis-induced cardiomyopathy: five typical categories. Chin Med J (Engl). 2020; 133(18):2205-2211. doi:10.1097/CM9.0000000000000929

  15. Geri G, Vignon P, Aubry A, Fedou AL,et al. Cardiovascular clusters in septic shock combining clinical and echocardiographic parameters: a post hoc analysis. Intensive Care Med 2019; 45:657–667. doi: 10.1007/s00134-019-05596-z. [PubMed] [Google Scholar]

  16. Vallabhajosyula S, Wang Z, Murad MH, et al. Natriuretic Peptides to Predict Short-Term Mortality in Patients With Sepsis: A Systematic Review and Meta-analysis. Mayo Clin Proc Innov Qual Outcomes. 2020;4(1):50-64. Published 2020 Jan 8. doi: 10.1016/j.mayocpiqo.2019.10.008.

  17. R. Sato, M. Nasu. A review of sepsis-induced cardiomyopathy.J Intensive Care, 3 (2015), pp. 48 http://dx.doi.org/10.1186/s40560-015-0112-5 | Medline

  18. Zhou X, Liu D, Su L, Yao B,et al. Use of stepwise lactate kinetics-oriented hemodynamic therapy could improve the clinical outcomes of patients with sepsis-associated hyperlactatemia. Critical Care., 21 (2017), pp. 33 http://dx.doi.org/10.1186/s13054-017-1617-1 | Medline.

  19. Landesberg G, Levin P.D, Gilon D, et al.Myocardial dysfunction in severe sepsis and septic shock: No correlation with inflammatory cytokines in real-life clinical setting.Chest., 148 (2015), pp. 93-102.

  20. Kotecha AA, Vallabhajosyula S, Apala DR, Frazee E, Iyer VN. Clinical outcomes of weight- based norepinephrine dosing in underweight and morbidly obese patients: a propensity-matched analysis. J Intensive Care Med. 2018:885066618768180. [ Links ] .

  21. Vallabhajosyula S, Jentzer JC, Kotecha AA, et al. Development and performance of a novel vasopressor-driven mortality prediction model in septic shock. Ann Intensive Care. 2018;8(1):112. [ Links ]

  22. Vallabhajosyula S, Jentzer JC, Geske JB,et al. New-onset heart failure and mortality in hospital survivors of sepsis-related left ventricular dysfunction. Shock 2018; 49:144–149. doi: 10.1097/SHK.0000000000000952.




2020     |     www.medigraphic.com